Swiss Pharmaceuticals ENDUROBOL GW 501516 Swiss Pharmaceuticals

£61.00

GW-501516 Endurobol is a potent PPARδ agonist studied for metabolic pathway modulation. This Swiss Pharmaceuticals formulation offers researchers a well-characterized compound for investigating fatty acid oxidation mechanisms.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Swiss Pharmaceuticals ENDUROBOL GW 501516 Swiss Pharmaceuticals
Swiss Pharmaceuticals ENDUROBOL GW 501516 Swiss Pharmaceuticals
£61.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Research Compound Profile

GW-501516 Endurobol is a peroxisome proliferator-activated receptor delta (PPARδ) agonist extensively studied in metabolic research applications. This compound from Swiss Pharmaceuticals represents a key tool for researchers investigating energy metabolism pathways and fatty acid oxidation mechanisms. Scientists at Stroid UK Shop can access this well-characterized metabolic modulator for comprehensive laboratory investigations examining cellular energy expenditure and metabolic gene expression.

Laboratory Applications

Research teams utilize GW-501516 to examine PPARδ receptor activation and downstream metabolic signaling cascades in cellular models. The compound demonstrates significant value in studies investigating mitochondrial function, lipid metabolism, and energy homeostasis pathways. Investigators studying metabolic disorders frequently incorporate this compound alongside other research tools from our Endurobol collection to examine complex metabolic interactions. Laboratory protocols often combine GW-501516 with compounds from our SARMs category to investigate tissue-selective metabolic effects. Research teams examining comprehensive metabolic pathways may also incorporate tools from our peptides section for multi-target investigation protocols.

Technical Specifications

GW-501516 Research Parameters
Parameter Specification
CAS Number 317318-70-0
Molecular Formula C₂₁H₁₈F₃NO₃S₂
Molecular Weight 453.50 g/mol
Classification PPARδ Receptor Agonist
Storage Requirements Room temperature, protect from light
Research Grade Laboratory use only

Research Compliance Statement

GW-501516 Endurobol from Swiss Pharmaceuticals is manufactured exclusively for in-vitro research applications and laboratory studies. This compound is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must ensure proper handling protocols and maintain appropriate documentation for all experimental procedures involving this metabolic modulator.

Related